Newswire

CDC Rescinds Telework Policy Amid Concerns for Employees with Disabilities

The Centers for Disease Control and Prevention (CDC) has reversed a recent decision to pause remote work for its employees, including those with disabilities, following significant backlash. Emails obtained by STAT reveal that the acting director of the CDC’s human resources office, Nathan Wells, instructed senior leaders to refrain from immediate action, citing the necessity for further clarification and coordination with the Department of Health and Human Services regarding an overarching telework policy.

This development underscores the ongoing challenges faced by organizations in balancing operational efficiency with the needs of a diverse workforce. The initial pause had raised concerns about potential discrimination against employees with disabilities, prompting advocacy and scrutiny from various stakeholders. As regulatory and compliance professionals in the pharma sector navigate similar workforce issues, this incident serves as a reminder of the importance of inclusive policies that accommodate all employees while ensuring organizational objectives are met.

Explore deeper: the API & FDF Intelligence database is more than a directory. It combines global coverage of APIs, excipients, and finished dosage forms with real market intelligence. You’ll find: – Price ranges for APIs, excipients, and formulations. – DMF, CEP, and GMP compliance status. – Manufacturer portfolios by product and geography. – Direct contacts for every producer and FDF holder, ready for outreach. Instead of scattered spreadsheets and endless searches, the entire picture is a few clicks away. Subscription starts at an accessible rate — see how much time and budget you save by centralizing everything.
Start your 7-day trial and see what the database can do →